Byungsoo Kang has a total of 88 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Integrating Explainable Diagnosis, Digital Health, and Life-Stage-Specific Korean Medicine for Obesity Management: A Narrative Synthesis of the Daeat Conference 2026

    by Byungsoo Kang, Chang-Eop Kim, Jiyoung Son, Chan-Young Kwon, Boram Lee

    Obesity is a heterogeneous chronic disease that requires diagnostic, behavioral, and life-stage-specific approaches beyond body mass index-centered assessment. In this short communication, the 5 invited speakers’ presentations from the Daeat Conference 2026 were reviewed and the content was organized into 4 research domains for Korean medicine (KM) obesity care. These were (1) interpretable diagnosis; (2) digital phenotyping and hybrid care; (3) life-stage-specific management; and (4) response-based personalization. Interpretable diagnosis was framed as a proposed modeling approach which maps multidimensional clinical observations onto inspectable diagnostic structures. Digital phenotyping was considered as a means of extending behavioral measurement beyond clinical consultations while preserving clinician-led care. Life-stage-specific management emphasized sarcopenic obesity and functional outcomes in older adults, while highlighting growth, development, and evidence gaps in children and adolescents. Response-based personalization distinguished nutritional input from interindividual metabolic and behavioral variability. Across these domains, several priorities for future research emerged, including standardized outcomes, longitudinal data, pragmatic multicenter studies, and appropriate data governance. These themes represent potential research directions rather than established evidence of clinical effectiveness.

  • Clinical Outcomes of Korean Medicine Care for Older Adults with Musculoskeletal Pain at a Senior Welfare Center: A Retrospective Observational Study

    by Chaeyeon Lee, Yeji Sohn, Yun Choi, Byungsoo Kang

    Chaeyeon Lee, Student, Yeji Sohn, Student, Yun Choi, Student, Byungsoo Kang, K.M.D.. J Korean Med Rehabi 2026;36:205-20. https://doi.org/10.18325/jkmr.2026.36.4.205

  • Open Access

    Acceptability of a Korean Medicine-Based Obesity Program Among Patients Achieving Predefined Weight-Loss Targets: A Retrospective Mixed-Methods Study

    by Ayusha Pandey, Dasol Park, Suyong Shin, Jungsang Kim, Minwhee Kang, Donghun Lee, Junho Kim, Chunghee Kim, Jiyoung Son, Seonghyeon Jeon, et al.

    Background and Objectives: Although herbal medicine-based obesity treatment programs are used in obesity management, empirical research on patient acceptability remains limited. This study examined acceptability of a Korean medicine-based obesity treatment program (KM-OBP) among patients who achieved predefined weight-loss targets in routine clinical care. Materials and Methods: Medical records and satisfaction survey data routinely collected during clinical practice at a single Korean medicine clinic were retrospectively analyzed. Patients had baseline body mass index (BMI) ≥ 30 kg/m2 and achieved both ≥10% weight loss and BMI ≤ 23 kg/m2 during follow-up. BMI trajectories and adverse-event occurrence were summarized descriptively. Satisfaction ratings were reported on a 5-point Likert scale, and free-text responses were retrospectively analyzed using the Theoretical Framework of Acceptability. Results: Of 3798 patients with a baseline BMI ≥ 30 kg/m2 and at least two BMI measurements, 37 (0.97%) met the predefined targets; 16 completed the satisfaction survey. Mean BMI change from the first to last measurement was −8.9 kg/m2, and median change was −8.8 kg/m2 (interquartile range, −9.6 to −7.7). Common documented adverse events were constipation, nausea, and dizziness. Satisfaction ratings were descriptively high for the overall program, perceived helpfulness for obesity treatment, and herbal medicine. Among the 16 survey respondents, perceived weight-loss benefits, program structure, safety, and health improvement were described as facilitators of acceptability, whereas post-treatment weight regain, dietary burden, and financial concerns were described as barriers. Conclusions: The findings characterize satisfaction and reported acceptability experiences among survey respondents within a highly selected target-achieving cohort. Interpretation is limited by outcome-based selection, potential non-response bias, the small survey sample, and the single-center design.

  • Open Access

    Weight Change After Korean Medicine Weight Management Treatment Combined with a Low-Carbohydrate Diet in Patients with Post-COVID-19 Condition: A Retrospective Multicenter Observational Study

    by Minwoo Bang, Suyong Shin, Jungsang Kim, Minwhee Kang, Donghun Lee, Junho Kim, Chunghee Kim, Jiyoung Son, Seonghyeon Jeon, Byungsoo Kang

    Objectives: To retrospectively describe weight change after Korean medicine weight management treatment combined with a low-carbohydrate diet (LCD) in patients with post-COVID-19 condition.Methods: This multicenter retrospective observational study used electronic medical records from eight Korean medicine clinics. Patients with post-COVID-19 condition who received Korean medicine weight management treatment for weight management and had paired baseline and follow-up body weight or body composition data were included. Primary outcomes were changes in body weight, body fat mass (BFM), and body mass index (BMI). Skeletal muscle mass (SMM), percent body fat (%BF), blood pressure, heart rate, laboratory parameters, handgrip strength, and adverse events were assessed as exploratory or descriptive outcomes. Paired comparisons were analyzed using the Wilcoxon signed-rank test.Results: Eleven patients were included. Body weight decreased from 69.66±16.50 kg to 64.14±15.55 kg (p=0.005), BFM from 27.03±8.72 kg to 22.66±6.58 kg (p=0.024), and BMI from 27.07±4.99 kg/m² to 24.85±4.08 kg/m² (p=0.007). Changes in SMM and %BF were not statistically significant. Other secondary variables, including blood pressure, heart rate, HbA1c, laboratory parameters, and handgrip strength, were limited or measured at heterogeneous time points and were therefore interpreted descriptively. Mild adverse events occurred in 5 of 11 patients (45.5%), with no severe adverse events.Conclusions: Korean medicine weight management treatment combined with LCD was associated with reduced body weight, BFM, and BMI in patients with post-COVID-19 condition, including some with baseline BMI below 23 kg/m². This study did not systematically evaluate long COVID-related symptom improvement. Larger prospective studies are needed.

  • Open Access

    Changes in Glycemic Control and Body Composition after Combined Herbal Medicine and Low-Carbohydrate Dietary Guidance in Patients with Prediabetes: A Multicenter Retrospective Observational Study

    by Ji-Young Son, Min-Woo Bang, Su-Yong Shin, Jung-Sang Kim, Min-Whee Kang, Dong-Hun Lee, Jun-Ho Kim, Chung-Hee Kim, Seong-Hyeon Jeon, Byung-Soo Kang

    Objectives: To evaluate short-term changes in glycated hemoglobin (HbA1c) and body composition after treatment with herbal medicine and a low-carbohydrate diet in patients with prediabetes.Methods: This multicenter retrospective study analyzed 58 patients with prediabetic (HbA1c 5.7-6.4%) treated with Ephedra-based herbal pills and a low-carbohydrate diet for 90-120 days. Changes in weight, body composition, HbA1c, and vitals were assessed.Results: Median body weight decreased significantly from 72.05 kg to 66.80 kg (p<0.001), accompanied by significant reductions in body fat. Median HbA1c decreased from 6.00% to 5.80% (p<0.001). HbA1c reduction showed no linear correlation with weight loss magnitude. Blood pressure decreased, whereas mild heart rate increases were observed.Conclusions: Herbal medicine combined with a low-carbohydrate diet was associated with short-term changes in body weight, body fat, and HbA1c in patients with prediabetes. However, as herbal medicine, low-carbohydrate diet, and adjunctive treatments were applied together, the independent contribution of herbal medicine could not be determined.

  • Open Access

    Association Between Herbal Medicine Treatment and Weight loss in Overweight and Obese Patients with Hypothyroidism: A Retrospective Multicenter Study

    by Da-Hee Jeong, Min-Woo Bang, Su-Yong Shin, Jung-Sang Kim, Min-Whee Kang, Dong-Hun Lee, Jun-Ho Kim, Chung-Hee Kim, Ji-Young Son, Seong-Hyeon Jeon, et al.

    Objectives: This study aimed to evaluate the association between herbal medicine treatment and weight change in overweight and obese patients with hypothyroidism. Methods: A retrospective multicenter study was conducted using medical records from eight Korean medicine clinics. A total of 72 patients with hypothyroidism and a body mass index (BMI)≥23 kg/m2 who received herbal medicine treatment for at least 4 months were included. Body composition parameters were assessed using bioelectrical impedance analysis, including body weight, BMI, body fat mass, percent body fat, and total body water. Hemodynamic parameters and adverse events were also evaluated. Paired t-tests were used to compare pre- and post-treatment outcomes.Results: After 4 months of treatment, significant reductions were observed in all body composition variables. Mean body weight decreased from 73.74±13.08 kg to 67.19±12.19 kg (mean change: -6.55±3.24 kg, p<0.001), and BMI decreased from 28.96±4.49 to 26.54±4.47 kg/m2 (p<0.001). Body fat mass and percent body fat also significantly decreased (p<0.001). For hemodynamic parameters, systolic and diastolic blood pressure significantly decreased, whereas heart rate increased. Mild adverse events were reported, but no serious adverse events were observed.Conclusion: These findings suggest that herbal medicine-based weight management may be associated with clinically meaningful weight reduction in overweight and obese patients with hypothyroidism. Given the retrospective design, concurrent dietary intervention, and lack of detailed thyroid function data, further prospective controlled studies are warranted to confirm these findings.

  • Open Access

    Weight Loss Goals and Lifestyle Characteristics of Mongolian Participants in Korean Medicine-Based Weight Management Consultation: An Exploratory Cross-Sectional Survey

    by Minwoo Bang, Suyong Shin, Jungsang Kim, Minwhee Kang, Donghun Lee, Junho Kim, Chunghee Kim, Jiyoung Son, Seonghyeon Jeon, Byungsoo Kang

    Objectives: Mongolia has experienced a rapid nutrition transition accompanied by increasing obesity prevalence. This study aimed to describe weight loss goals, lifestyle characteristics, and health-related features among Mongolian participants who voluntarily attended a Korean Medicine (KM)-based weight management consultation event.Methods: This exploratory cross-sectional study was conducted among Mongolian participants who voluntarily attended a KM-based weight management consultation event in Ulaanbaatar. Data collected included demographic characteristics, body mass index (BMI), desired and physician-recommended weight loss, food preferences, eating patterns, sleep patterns, alcohol preferences, and general health conditions.Results: Forty participants (95% female; mean age 42.5 years) were enrolled, and most were overweight or obese. On average, participants desired a weight reduction of 14.2±8.9 kg (17.9±7.5%), which was slightly higher than the mean physician-recommended target. In self-reported responses, participants frequently selected red meat and refined grains as preferred foods, whereas fruit and vegetable preferences were less frequently selected. Sleep-related problems were self-reported by 72.5% of participants. Beer was the most frequently preferred alcoholic beverage, and social media was the primary referral pathway (72.5%).Conclusions: This exploratory cross-sectional survey provides preliminary descriptive data on weight loss goals, lifestyle characteristics, health-related features, and referral pathways among Mongolian participants in a KM-based weight management consultation event. These findings should be interpreted as preliminary self-reported responses from a non-validated pre-consultation questionnaire and may inform culturally tailored pre-treatment counseling programs and future intervention studies.

  • Open Access

    Effects of Herbal Medicine in Obese Patients with Persistent Alcohol Consumption: Two Case Reports on Weight Loss with Muscle Mass Maintenance and Improvement of Liver Function

    by Da-Hee Jeong, Min-Woo Bang, Su-Yong Shin, Jung-Sang Kim, Min-Whee Kang, Dong-Hun Lee, Jun-Ho Kim, Chung-Hee Kim, Ji-Young Son, Seong-Hyeon Jeon, et al.

    Objectives: This study aimed to evaluate the effects of herbal medicine treatment on body composition and liver function in obese patients with persistent heavy alcohol consumption.Methods: Two patients with severe obesity and persistent heavy alcohol consumption were observed for changes in body composition and liver function over a 5-6-month period of herbal medicine treatment. Clinical parameters, including body weight, body mass index, body fat mass, skeletal muscle mass, and total body water, were evaluated at baseline and post-treatment. Liver function was also assessed using laboratory tests, including aspartate aminotransferase (AST), alanine aminotransferase (ALT), and gamma-glutamyl transferase (GGT) levels. Adverse events were evaluated using the Common Terminology Criteria for Adverse Events and the World Health Organization-Uppsala Monitoring Centre criteria.Results: In case 1 (44-year-old woman), body weight decreased from 90.1 to 80.8 kg, with an 8.6 kg reduction in fat mass, and elevated AST and ALT levels normalized. In case 2 (35-year-old man), body weight decreased from 116.5 to 91.1 kg, with a 21.1 kg reduction in fat mass, and elevated GGT levels normalized. In both cases, skeletal muscle mass was relatively preserved despite significant weight loss. No clinically significant adverse events were observed.Conclusion: This case series suggests that herbal medicine treatment may induce weight loss and improve liver function without significant muscle loss, even in obese patients who continue heavy alcohol consumption.

  • Open Access

    Clinical Research Trends of Traditional Chinese Medicine Interventions for Obesity: A Scoping Review

    by In-Woo Choi, Min-Woo Bang, Su-Yong Shin, Jung-Sang Kim, Min-Whee Kang, Dong-Hun Lee, Jun-Ho Kim, Chung-Hee Kim, Ji-Young Son, Seong-Hyeon Jeon, et al.

    Objectives: This study aims to map clinical research trends in traditional Chinese medicine (TCM) interventions for obesity in China over the past 5 years.Methods: A scoping review of articles published between 2021 and 2025 in PubMed, EMBASE, and Scopus databases was conducted.Results: Twenty-six studies were included, predominantly randomized controlled trials (RCTs; 88.5%). Acupoint catgut embedding (12 studies) was the most frequent intervention. Studies generally reported improvements in anthropometric indices, lipid metabolism, and insulin resistance. Multi-modality approaches and modern mechanistic evaluations (e.g., functional magnetic resonance imaging [fMRI], gut microbiota) were notable trends. Among the studies that explicitly reported safety outcomes, severe adverse events were rarely observed.Conclusion: TCM, especially catgut embedding, is actively used to treat obesity in China, with a high proportion of studies adopting RCT designs. Future studies require standardized protocols and long-term follow-up to further evaluate clinical efficacy and safety.

  • Open Access

    Changes in Continuous Glucose Monitoring Metrics During the Initial Phase of a Korean Medicine–Based Weight Reduction Program: A Retrospective Observational Study

    by Minwoo Bang, Suyong Shin, Jungsang Kim, Minwhee Kang, Donghun Lee, Junho Kim, Chunghee Kim, Jiyoung Son, Seonghyeon Jeon, Byungsoo Kang

    Objectives: This multicenter retrospective study evaluated early changes in continuous glucose monitoring (CGM) metrics and metabolic parameters during the initial phase of a Korean medicine (KM) based weight loss program combined with a low-carbohydrate diet (LCD).Methods: Thirty-one participants who wore a CGM device for 14–15 days after starting KM treatment and LCD were analyzed. Weekly CGM metrics, daily trends using linear mixed-effects models, and 1-month changes in body composition and metabolic indicators were assessed.Results: Time in range (TIR) increased by 8.46 percentage points, and coefficient of variation decreased from 0.15 to 0.13, both meeting minimally clinically important difference criteria. The percentage of time below range (TBR) <54 mg/dL decreased from 0.44% to 0.03%. Daily trend analyses revealed significant improvements in TIR and time above range (TAR). After one month, body weight decreased by 3.6 kg, BMI by 1.3 kg/m², and systolic, diastolic blood pressure by 5.6, 4.5 mmHg; HbA1c decreased by 0.4%.Conclusion: KM treatment combined with an LCD produced clinically meaningful early improvements in CGM variability and short-term metabolic outcomes, suggesting potential as an integrative metabolic intervention.